Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Satyen H. Gohil et al.|Cancer Cell|2021Cited by 515
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor CellsKathleen M. Mahoney, Gordon J. Freeman|Cancer Immunology Research|2015Cited by 126
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean‐Christophe Pignon, Sabina Signoretti, Opeyemi A. Jegede et al.|Clinical Cancer Research|2019Cited by 121